Your browser doesn't support javascript.
loading
Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity.
Jedema, I; Barge, R M Y; van der Velden, V H J; Nijmeijer, B A; van Dongen, J J M; Willemze, R; Falkenburg, J H F.
Affiliation
  • Jedema I; Laboratory of Experimental Hematology, Department of Hematology, Leiden University Medical Center, The Netherlands. i.jedema@lumc.nl
Leukemia ; 18(2): 316-25, 2004 Feb.
Article in En | MEDLINE | ID: mdl-14614514
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antigens, Differentiation, Myelomonocytic / Leukemia / Antigens, CD / Cell Cycle / Endocytosis / Aminoglycosides / Antibodies, Monoclonal Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2004 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antigens, Differentiation, Myelomonocytic / Leukemia / Antigens, CD / Cell Cycle / Endocytosis / Aminoglycosides / Antibodies, Monoclonal Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2004 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom